OR56A1

Across TCGA pan-cancer cohorts, OR56A1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated OR56A1 data layer compared with 12 for mass-spec protein.

The strongest signal is observed in kidney chromophobe (KICH), where higher OR56A1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR56A1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

KICH, OV, and BRCA are the cancer types where OR56A1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Median	All	0.081	0.904	<.001	30	view →
OV	DFS	Median	II,III,IV	0.182	0.541	.011	30	view →
BRCA	OS	Median	All	0.592	0.924	<.001	22	view →
UCEC	DFS	Median	II,III,IV	1.000	0.440	.026	8	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

OR56A1–KICH (DFS)

Open the KICH breakdown →